Oxacillin
NDC Package 76126-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Oxacillin is used to treat a wide variety of bacterial infections. Marketed by Agila Specialties Private Limited, this product is identified by NDC 76126-101 and is authorized under FDA application ANDA091486.

Identification & Billing

NDC Package Code
76126-101-01
Package Description
10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code
76126-101
11-Digit Billing Format
76126010101

Clinical Specifications

Proprietary Name
Oxacillin
Dosage Form
-
Usage Information
Oxacillin is used to treat a wide variety of bacterial infections. It is a penicillin antibiotic. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Agila Specialties Private Limited
FDA Application #
ANDA091486
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-26-2014
End Marketing Date
09-01-2017
Listing Expiration
09-01-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76126-101-01 identifies a specific commercial package of 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial of Oxacillin, labeled by Agila Specialties Private Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Agila Specialties Private Limited on August 26, 2014. The current certification is valid through September 01, 2017.

What are the primary indications for this medication?

Oxacillin is used to treat a wide variety of bacterial infections. It is a penicillin antibiotic. It works by stopping the growth of bacteria.

How is this Agila Specialties Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76126010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76126-101-01
11-Digit CMS (5-4-2)
76126-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.